Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
3186studies shown
Showing 2,501-2,525 of 3,186
CompletedNCT03447548

Neurofeedback Training for High Risk Psychosis

This study exists to compare options and see whether this type of care offers something meaningfully different. Researchers are trying to understand whether this type of care can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 12 Years to 25 Years
Countries
United States
Sponsor
Hartford Hospital
Condition
Schizophrenia
CompletedNCT02822092

Striatal Connectivity and Clinical Outcome in Psychosis

This study exists to see whether blood tests and biological markers can make care clearer and more responsive. Researchers are trying to understand whether blood tests and biological markers can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 15 Years to 40 Years
Countries
United States
Sponsor
Northwell Health
Condition
Schizophrenia
TerminatedNCT05526833

An Extension Protocol for Patients Who Previously Completed the TMS Pilot Study

This study exists to understand how a digital app or remote support tool holds up over time after the earliest research stage. Researchers are trying to understand whether a digital app or remote support tool can give earlier or clearer feedback during care.

SchizophreniaOtherFrom 22 Years to 55 Years
Countries
United States
Sponsor
Columbia University
Condition
Schizophrenia
CompletedNCT00727103

Varenicline Treatment in Alcohol and Nicotine Dependent Patients With Schizophrenia

This study exists to see whether smoking support or smoking-related treatment is workable and worth testing more broadly. Researchers are trying to understand whether smoking support or smoking-related treatment can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 69 Years
Countries
United States
Sponsor
State University of New York - Upstate Medical University
Condition
Schizophrenia
CompletedNCT04559529

Pharmacological Modulation of Hippocampal Activity in Psychosis 2

This study exists to explore whether blood tests and biological markers could improve care and understanding. Researchers are trying to understand what blood tests and biological markers can reveal about signals in the brain or body that may guide care later on.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
Vanderbilt University Medical Center
Condition
Schizophrenia
CompletedNCT02022462

Project Bridge: Peer Health Navigator Intervention

This study exists to see whether a digital app or remote support tool can make care clearer and more responsive. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
University of Southern California
Condition
Schizophrenia
CompletedNCT06231407

Increasing Medication Check Participation Through Applying CT-r

This study exists to see whether a therapy or guided support program is workable and worth testing more broadly. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 80 Years
Countries
United States
Sponsor
Vanderbilt University Medical Center
Condition
Schizophrenia
CompletedNCT04158687

A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-692 as an Adjunctive Treatment in Adults With Schizophrenia

This study exists to understand whether the medication CTP-692 is both safe enough and useful enough to take further. Researchers are trying to understand how people respond to the medication CTP-692 in practice and what may need to be adjusted.

SchizophreniaOtherFrom 18 Years to 55 Years
Countries
United States
Sponsor
Concert Pharmaceuticals
Condition
Schizophrenia
CompletedNCT03198078

Trial to Evaluate the Short-term Safety & Efficacy of Brexpiprazole Monotherapy in the Treatment of Adolescents With Schizophrenia

This study exists to understand whether a therapy or guided support program is both safe enough and useful enough to take further. Researchers are trying to understand how people respond to a therapy or guided support program in practice and what may need to be adjusted.

SchizophreniaOtherFrom 13 Years to 17 Years
Countries
United States
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition
Schizophrenia
CompletedNCT04659161

A Study to Assess Efficacy and Safety of KarXT in Acutely Psychotic Hospitalized Adult Patients With Schizophrenia (EMERGENT-2)

This study exists to compare options and see whether this type of care offers something meaningfully different. Researchers are trying to understand how people respond to this type of care in practice and what may need to be adjusted.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Condition
Schizophrenia
CompletedNCT04783246

Virtual Group Fitness and Nutrition Intervention for Individuals With Psychosis

This study exists to see whether a digital app or remote support tool is workable and worth testing more broadly. Researchers are trying to understand whether a digital app or remote support tool can make support easier to access outside standard clinic visits.

SchizophreniaOtherOver 18 Years
Countries
United States
Sponsor
Boston Medical Center
Condition
Schizophrenia
TerminatedNCT04203056

Aripiprazole Lauroxil for Preventing Psychotic Relapse After an Initial Schizophrenia Episode

This study exists to compare options and see whether a digital app or remote support tool offers something meaningfully different. Researchers are trying to understand whether a digital app or remote support tool can give earlier or clearer feedback during care.

SchizophreniaOtherFrom 18 Years to 45 Years
Countries
United States
Sponsor
University of California, Los Angeles
Condition
Schizophrenia
CompletedNCT03859973

This Study Tests Whether BI 425809 Together With Brain Training Using a Computer Improves Mental Functioning in Patients With Schizophrenia

This study exists to compare options and see whether a medication treatment offers something meaningfully different. Researchers are trying to understand what a medication treatment can reveal about signals in the brain or body that may guide care later on.

SchizophreniaOtherFrom 18 Years to 50 Years
Countries
Australia, Canada, France, New Zealand, United Kingdom, United States
Sponsor
Boehringer Ingelheim
Condition
Schizophrenia
CompletedNCT02708940

Participatory Messaging in the UCLA Psychiatry Partial Hospitalization and Intensive Outpatient Programs

This study exists to see whether cognitive behavioural therapy, a structured talking treatment, is workable and worth testing more broadly. Researchers are trying to understand whether cognitive behavioural therapy, a structured talking treatment, can improve attention, thinking, or day-to-day functioning.

SchizophreniaOther
Countries
United States
Sponsor
University of California, Los Angeles
Condition
Schizophrenia
CompletedNCT03975400

Using Digital Media Advertising to Reduce the Duration of Untreated Psychosis

This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

SchizophreniaOther
Countries
United States
Sponsor
Northwell Health
Condition
Schizophrenia
CompletedNCT02008292

Acetylcholine, Tobacco Smoking, Genes and Nicotinic Receptors

This study exists to compare options and see whether smoking support or smoking-related treatment offers something meaningfully different. Researchers are trying to understand whether smoking support or smoking-related treatment can give earlier or clearer feedback during care.

SchizophreniaOtherFrom 18 Years to 60 Years
Countries
United States
Sponsor
Yale University
Condition
Schizophrenia
RecruitingNCT04940663

Neurobehavioral Mechanisms of Social Isolation and Loneliness in Serious Mental Illness

This study exists to understand what helps a digital app or remote support tool work in everyday practice, not just under ideal conditions. Researchers are trying to understand whether a digital app or remote support tool can make support easier to access outside standard clinic visits.

SchizophreniaOtherFrom 18 Years to 55 Years
Countries
United States
Sponsor
Massachusetts General Hospital
Condition
Schizophrenia
CompletedNCT04512066

A Trial of the Efficacy and the Safety of RO6889450 (Ralmitaront) vs Placebo in Patients With an Acute Exacerbation of Schizophrenia or Schizoaffective Disorder

This study exists to understand whether a therapy or guided support program is both safe enough and useful enough to take further. Researchers are trying to understand how people respond to a therapy or guided support program in practice and what may need to be adjusted.

SchizophreniaOtherFrom 18 Years to 45 Years
Countries
Japan, Russian Federation, Ukraine, United States
Sponsor
Hoffmann-La Roche
Condition
Schizophrenia
CompletedNCT02958007

Peer Support for Exercise in Older Veterans With Psychotic Disorders

This study exists to see whether a guided support group is workable and worth testing more broadly. Researchers are trying to understand whether a guided support group can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherOver 50 Years
Countries
United States
Sponsor
VA Office of Research and Development
Condition
Schizophrenia
CompletedNCT06038786

Resiliency Training on the College Campus

This study exists to compare options and see whether this type of care offers something meaningfully different. For people living with Anxiety, that matters because care needs to work in daily life, not just in theory.

AnxietyOtherFrom 18 Years to 30 Years
Countries
United States
Sponsor
Massachusetts General Hospital
Condition
Anxiety
CompletedNCT05352568

Is Cognitive Training an Option?

This study exists to see whether a digital app or remote support tool is workable and worth testing more broadly. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
Alliant International University
Condition
Schizophrenia
WithdrawnNCT03464162

OnTrackNY With the Option of Social Network Meetings

This study exists to understand what helps a therapy or guided support program work in everyday practice, not just under ideal conditions. Researchers are trying to understand what helps a therapy or guided support program stay useful, realistic, and easier to follow over time.

SchizophreniaOtherOver 16 Years
Countries
United States
Sponsor
Lisa Dixon
Condition
Schizophrenia
CompletedNCT04309370

Interactions of Fronto-Parietal High Frequency rTMS on Anterior Cingulate Cortex Activation in Schizophrenia

This study exists to see whether brain scans or other body measurements is workable and worth testing more broadly. Researchers are trying to understand whether brain scans or other body measurements can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 40 Years
Countries
United States
Sponsor
Indiana University
Condition
Schizophrenia